Answers are grounded in this paper and cite their sources.
The SRQoL is a new PRO instrument to assess Sjögren's impact on HRQoL, developed in accordance with regulatory guidance. This study provides considerable insight into the patient experience of Sjögren's and evidence to support the content validity of the SRQoL. Future research should evaluate the psychometric properties of the SRQoL to support its use in clinical trials and clinical practice and further validate its use as an assessment of treatment benefit.
No takes yet. Share an insight, caveat, or question.
Marvel et al. (2024) studied this question.
Synapse has enriched 5 related papers. Consider them for comparative context: